Aldatu Biosciences

Boston, United States Founded: 2014 • Age: 12 yrs
Diagnostic tools for infectious diseases are developed using genotyping platforms.
Annual revenue - Latest available
Total funding - 8 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 4 Services tracked
Competitors 11 Brand Intelligence

About Aldatu Biosciences

Aldatu Biosciences is a company based in Boston (United States) founded in 2014. Aldatu Biosciences offers products and services including PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection. Aldatu Biosciences operates in a competitive market with competitors including BioLife Solutions, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.

  • Headquarter Boston, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aldatu Biosciences, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $3 M (USD), Grant

    Sep 12, 2022

  • Investors
    NIH

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aldatu Biosciences

Aldatu Biosciences offers a comprehensive portfolio of products and services, including PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection.

Primary

Adaptive PCR system for detecting viral variants in infectious diseases

Assays for detection and genotyping of SARS-CoV-2 variants

Tests for identifying drug-resistant HIV variants

PCR-based tests for detecting Lassa virus

People of Aldatu Biosciences

Headcount 10-50
Employee Profiles 12
Board Members and Advisors 2
Employee Profiles
People
Betsy Wonderly Trainor
VP Development
People
Mike Henry
Chief Business Officer
People
Larry Carrasco
Vice President Operations
People
Iain MacLeod
Co-Founder, CEO & CSO

Unlock access to complete

Funding Insights of Aldatu Biosciences

  • Total Funding
  • Total Rounds 8
  • Last Round Grant — $3.0M
  • First Round

    (12 Mar 2015)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2022 Amount Grant - Aldatu Biosciences Valuation

investors

NIH
Aug, 2022 Amount Grant - Aldatu Biosciences Valuation

investors

HHS
Mar, 2021 Amount Grant - Aldatu Biosciences Valuation

investors

HHS

Investors in Aldatu Biosciences

Aldatu Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and SBIR.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Federal innovation and scientific achievement services are provided.
Founded Year Domain Location

Investments & Acquisitions by Aldatu Biosciences

Investments

Financial Statements - Aldatu Biosciences

Aldatu Biosciences Comparisons

+
Add Comparison
Available on Premium

Competitors of Aldatu Biosciences

Aldatu Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Genomic and theranostic services for oncology precision medicine are delivered.
domain founded_year HQ Location
Proprietary reagents for single-cell genetic analysis are developed.
domain founded_year HQ Location
Speech recognition solutions are provided by Inscripta for healthcare professionals.

Latest news on Aldatu Biosciences

Frequently Asked Questions about Aldatu Biosciences

Aldatu Biosciences was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Aldatu Biosciences is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Aldatu Biosciences was founded in 2014 in Boston, United States, within the biotechnology sector. Operations center on the development of diagnostic solutions for infectious diseases, leveraging the proprietary PANDAA platforma modified qPCR protocolfor detecting HIV drug resistance in patient samples. A 1.5 million grant from the NIH was awarded in March 2015 to support test advancement. The domain aldatubio.com is utilized for online presence.

Aldatu Biosciences's top competitors include Sino Biological, OncoDNA and RoosterBio.

Aldatu Biosciences offers PANDAA Platform, SARS-CoV-2 Tests, HIV Drug Resistance Tests, and Lassa Virus Detection.

Aldatu Biosciences has 3 investors. Key investors include NIH, HHS, and SBIR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available